Cargando…

Stem/Progenitor Cells and Related Therapy in Bronchopulmonary Dysplasia

Bronchopulmonary dysplasia (BPD) is a chronic lung disease commonly seen in preterm infants, and is triggered by infection, mechanical ventilation, and oxygen toxicity. Among other problems, lifelong limitations in lung function and impaired psychomotor development may result. Despite major advances...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marega, Manuela, El-Merhie, Natalia, Gökyildirim, Mira Y., Orth, Valerie, Bellusci, Saverio, Chao, Cho-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342250/ https://www.ncbi.nlm.nih.gov/pubmed/37446407 http://dx.doi.org/10.3390/ijms241311229

Ejemplares similares

The Role of Insulin Receptor Substrate Proteins in Bronchopulmonary Dysplasia and Asthma: New Potential Perspectives
por: Gorgisen, Gokhan, et al.
Publicado: (2022)

Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development
por: Shahzad, Tayyab, et al.
Publicado: (2016)

p16 (INK4a) and the Alveolar Niche Take Center Stage in Bronchopulmonary Dysplasia
por: Chao, Cho-Ming, et al.
Publicado: (2020)

A Breath of Fresh Air on the Mesenchyme: Impact of Impaired Mesenchymal Development on the Pathogenesis of Bronchopulmonary Dysplasia
por: Chao, Cho-Ming, et al.
Publicado: (2015)

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
por: Chao, Cho-Ming, et al.
Publicado: (2020)

Cross-Talk Between Inflammation and Fibroblast Growth Factor 10 During Organogenesis and Pathogenesis: Lessons Learnt From the Lung and Other Organs
por: Marega, Manuela, et al.
Publicado: (2021)

Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022)

When inflammation meets lung development—an update on the pathogenesis of bronchopulmonary dysplasia
por: Holzfurtner, Lena, et al.
Publicado: (2022)

Stem Cell Therapy for Bronchopulmonary Dysplasia: Bench to Bedside Translation
por: Ahn, So Yoon, et al.
Publicado: (2015)

Stem Cells and Their Mediators – Next Generation Therapy for Bronchopulmonary Dysplasia
por: Möbius, Marius A., et al.
Publicado: (2015)

Mesenchymal stromal/stem cells and bronchopulmonary dysplasia
por: Zhang, Shuqing, et al.
Publicado: (2023)

NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020)

Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia
por: Tang, Eireen, et al.
Publicado: (2022)

Refining anti‐inflammatory therapy strategies for bronchopulmonary dysplasia
por: Rudloff, Ina, et al.
Publicado: (2016)

Phenotypes of Bronchopulmonary Dysplasia
por: Wang, Shih-Hsin, et al.
Publicado: (2020)

Drug therapy for the prevention and treatment of bronchopulmonary dysplasia
por: Iyengar, Anjali, et al.
Publicado: (2015)

Application Prospects of Mesenchymal Stem Cell Therapy for Bronchopulmonary Dysplasia and the Challenges Encountered
por: Tong, Yajie, et al.
Publicado: (2021)

Circulating Endothelial Progenitor Cells Decrease in Infants with Bronchopulmonary Dysplasia and Increase after Inhaled Nitric Oxide
por: Qi, Yuanyuan, et al.
Publicado: (2013)

Editorial: Bronchopulmonary dysplasia: latest advances
por: Perveen, Shahana, et al.
Publicado: (2023)

FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells
por: Taghizadeh, Sara, et al.
Publicado: (2022)

Pulmonary Biomarkers of Bronchopulmonary Dysplasia
por: Thompson, Alecia, et al.
Publicado: (2008)

Incidence of Bronchopulmonary Dysplasia in Korea
por: Choi, Chang Won, et al.
Publicado: (2012)

Oxidative Stress and Bronchopulmonary Dysplasia
por: Perrone, Serafina, et al.
Publicado: (2012)

Present and Future of Bronchopulmonary Dysplasia
por: Bonadies, Luca, et al.
Publicado: (2020)

Perspectives on Probiotics and Bronchopulmonary Dysplasia
por: Yang, Kun, et al.
Publicado: (2020)

Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020)

Bronchopulmonary Dysplasia: Pathogenesis and Pathophysiology
por: Dankhara, Nilesh, et al.
Publicado: (2023)

Mesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasia
por: Möbius, Marius A., et al.
Publicado: (2016)

Endothelial progenitor cells derived from embryonic stem cells prevent alveolar simplification in a murine model of bronchopulmonary dysplasia
por: Kolesnichenko, Olena A., et al.
Publicado: (2023)

Cerebral Myelination in a Bronchopulmonary Dysplasia Murine Model
por: Chen, Wenwen, et al.
Publicado: (2023)

Pulmonary hypertension in infants with bronchopulmonary dysplasia
por: Kim, Gi Beom
Publicado: (2010)

Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Hospital management of severe bronchopulmonary dysplasia
por: Moretti, Corrado, et al.
Publicado: (2015)

Correlation of Retinopathy of Prematurity with Bronchopulmonary Dysplasia
por: Podraza, Wojciech, et al.
Publicado: (2018)

The rate and pattern of bronchopulmonary dysplasia in Kuwait
por: Al-Essa, Mazen, et al.
Publicado: (2004)

Impact of bronchopulmonary dysplasia on brain and retina
por: Poon, Annie Wing Hoi, et al.
Publicado: (2016)

Strategies to improve outcomes of bronchopulmonary dysplasia
por: Jung, Young Hwa, et al.
Publicado: (2019)

New Pharmacologic Approaches to Bronchopulmonary Dysplasia
por: Roberts, Katelyn, et al.
Publicado: (2021)

An Update on the Prevention and Management of Bronchopulmonary Dysplasia
por: Hennelly, Marissa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nnn3ubo4akn3l0mpf1sg7djk7v